PGP and acute myeloid leukemia: We posit that the cytotoxic benefits of the SL enzyme inhibitor regimen in drug-resistant AML are due in part to the interaction of D-threo-PDMP with P-gp, acting to block ceramide glycosylation and advancing ceramide-driven apoptosis that is co-assisted via AC inhibition.